. Author manuscript; available in PMC: 2011 Oct 1.

Published in final edited form as: Depress Anxiety. 2010 Oct;27(10):960–963. doi: 10.1002/da.20731

Table 1.

Clinical outcomes over time (Mean [SD] or N [%]).

Measure	Baseline (n=14)	3 days (n=12)	3 weeks (n=10)	6 weeks (n=9)
HDRS24	24.6 (5.6)	13.0 (6.1)^***	13.6 (7.6)^***	11.1 (7.7)^***
HAM-A	13.1 (3.9)	7.0 (4.3)^***	8.0 (4.7)^***	7.5 (3.5)^***
RBANS	97.8 (8.9)	102.0 (14.9)	103.0 (12.7)	105.5 (7.4)^*
BDI	27.8 (7.7)	15.8 (11.2)^***	18.3 (12.0)^***	15.4 (11.4)^***
Responders		6 (43%)	5 (36%)	5 (36%)
Remitters		4 (29%)	5 (36%)	4 (29%)

Mean [SD] are for all available data; missing values were not imputed. Response and remission rates were calculated in an intent-to-treat fashion. Significance reflects comparison to baseline:

p< 0.05;

^**

p<0.01;

^***

p< 0.001.

Responders defined by ≥50% decrease in HDRS24; Remitters defined by HDRS24 ≤10. HRSD24=24-item Hamilton Depression Rating Scale; HAMA=Hamilton Rating Scale for Anxiety; BDI=Beck Depression Inventory; RBANS=Repeatable Battery for the Assessment of Neuropsychological Status (total score).